Breast Care

Papers
(The median citation count of Breast Care is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer88
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 202150
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 202246
Breast Disorders in Adolescence: A Review of the Literature19
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer – A Brief Summary of the Consensus Discussion19
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 202118
HER2-Low Breast Cancer: Where Are We?16
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 202316
Diffusion-Weighted Imaging of Different Breast Cancer Molecular Subtypes: A Systematic Review and Meta-Analysis16
Resistance Exercise for Breast Cancer Patients? Evidence from the Last Decade15
Risk Factors for Idiopathic Granulomatous Mastitis Recurrence after Patient-Tailored Treatment: Do We Need an Escalating Treatment Algorithm?15
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 202314
Low-Dose Methotrexate Use in Idiopathic Granulomatous Mastitis: An Alternative Treatment Method13
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer13
CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis12
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 202212
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping11
False Negativity of Targeted Axillary Dissection in Breast Cancer11
Impact of Oncoplastic Breast Surgery on Rate of Complications, Time to Adjuvant Treatment, and Risk of Recurrence10
Treatment of Luminal Metastatic Breast Cancer beyond CDK4/6 Inhibition: Is There a Standard of Care in Clinical Practice?10
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis9
Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution8
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors7
Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo – Neotarget Trial7
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery7
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)7
ABC6 Consensus: Assessment by a Group of German Experts7
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?7
Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast7
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy7
Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Canc7
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer7
Long-Term Results of the TARGIT-A Trial: More Questions than Answers6
From <b><i>BRCA1</i></b> to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes6
Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia6
Patient-Reported Outcomes in Free-Flap Breast Reconstructive Surgery over Time (PRO-BREST)6
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases5
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet5
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review5
Multistage Latissimus Dorsi Flap with Implant for Complex Post-Mastectomy Reconstruction: An Old but Still Current Technique5
Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving5
Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment5
Augmented Reality in Breast Surgery Education5
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience5
Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer4
Assessment of MRI-Detected Breast Lesions: A Benign Correlate on Second-Look Ultrasound Can Safely Exclude Malignancy4
Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy4
Awareness and Availability of Routine Germline <b><i>BRCA1/2</i></b> Mutation Testing in Patients with Advanced Breast Cancer in Germany4
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period4
App-Based Lifestyle Coaching (PINK!) Accompanying Breast Cancer Patients and Survivors to Reduce Psychological Distress and Fatigue and Improve Physical Activity: A Feasibility Pilot Study4
Survey on Physicians’ Knowledge and Training Needs in Genetic Counseling in Germany4
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer4
Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis4
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer4
Long-Term Outcome Analysis and Technical Refinements after Autologous Breast Reconstruction with PAP Flap: What We Have Learnt4
The Role of Social Media and Breast Cancer: How Does It Impact Patients?4
Quality and Quantity: How to Organize a Countrywide Genetic Counseling and Testing4
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus4
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients3
Clinical Importance of PGRMC1 in Hormone Responsive Breast Cancer3
What Has Changed in Patients Aged 65 and over Diagnosed with Breast Cancer during the COVID-19 Pandemic: A Single-Center Experience3
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Muta3
Innovative Standards in Surgery of the Breast after Neoadjuvant Systemic Therapy3
Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis3
The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer3
Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria3
Innovative Standards in Oncoplastic Breast Conserving Surgery: From Radical Mastectomy to Extreme Oncoplasty3
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy3
First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center3
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)3
Evaluation of the Effect of Axillary Radiotherapy Dose and the Development of Lymphedema in Breast Cancer Patients3
Luminal Metastatic Breast Cancer: Current Concepts and Future Approaches3
The <b><i>CHEK2</i></b>*1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature2
The Impact of Breast Awareness on the Early Detection of Breast Cancer in Young Women: A Systematic Review2
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue2
Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure2
Breast Augmentation with Autologous Fat Grafting Immediately after Removal of Polyacrylamide Hydrogel and Fibrotic Capsule in 162 Patients2
Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis2
Impact of Diabetes on Patient Outcomes in Breast Cancer Patients2
Expert Discussion: Hypofractionated Radiation Therapy – Standard for All Indications?2
The Role of Social Media in Breast Cancer Care and Survivorship: A Narrative Review2
New Media Platforms for Teaching and Networking: Emerging Global Opportunities for Breast Surgeons2
First Prospective Cross-Sectional Study on the Impact of Immigration Background and Education in Early Detection of Breast Cancer2
Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer2
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer – Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)2
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences2
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment2
Primary Prevention and Early Detection of Hereditary Breast Cancer2
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard2
The Role of High Intensity Focused Ultrasound in the Treatment of Fibroadenomas: A Systematic Review2
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study2
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference2
Incorporating Genomic and Genetic Testing into the Treatment of Metastatic Luminal Breast Cancer2
Selective Extirpation of Tattooed Lymph Node in Combination with Sentinel Lymph Node Biopsy in the Management of Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy2
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer2
Pushing the Limits of Breast-Conserving Surgery with Extreme Oncoplasty2
Higher CD1a Levels Correlate with PD-L1 Expression and Predict Worse Overall Survival in Triple-Negative Breast Carcinoma2
Treatment Strategy for Patients with HR-Positive HER2-Negative Metastatic Breast Cancer That Progressed on CDK4/6 Inhibitors2
Human Acellular Dermal Matrix (Epiflex®) in Immediate Implant-Based Breast Reconstruction after Skin- and Nipple-Sparing Mastectomy and Treatment of Capsular Fibrosis: Results of a Multicenter, Prospe2
Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)2
When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions2
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes2
Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment: Long-Term Outcomes2
Risk and Survival of Third Primary Cancers in a Population-Based Cohort of Breast Cancer Patients2
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database2
Clinical Axillary Staging in Breast Cancer Patients Using Ultrasound Imaging1
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis1
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response1
Biomarkers: Which Ones Do We Really Need Today?1
Evolution of HER2 Targeting in Metastatic Breast Cancer1
A Preliminary Study of Ultrasound-Guided Microwave Ablation for Nonpuerperal Mastitis Treatment1
Are Diagnostic Delays Associated with Distress in Breast Cancer Patients?1
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer1
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib1
Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?1
Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer1
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions1
Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study1
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies1
Genetic Testing in Breast Cancer: New Standards of Care1
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level1
Oncoplastic Breast Conserving Surgery: Is There a Need for Standardization? Results of a Nationwide Survey1
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study1
Nationwide Survey of German Outpatient Gynecologic Oncology Practices during the Coronavirus Disease 2019 Pandemic: Reactions to the First Wave and Future Perspectives1
Expert Discussion: ASCO 20221
A Second Ductoscopy Procedure in Patients with Recurrent and Persistent Pathological Nipple Discharge1
PharmaNews1
Prevalence, Clinical Significance and Risk Factors for Developing Scar Pain and Sensibility Disorders in Breast Cancer Patients after Breast-Conserving Therapy and Mastectomy1
Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review1
Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer: Transforming Books into Data1
Expert Discussion: Highlights from the San Antonio Breast Cancer Symposium, San Antonio, December 8–11, 20201
The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study1
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients1
The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy1
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy1
Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases1
ABC7 Consensus: Assessment by a German Group of Experts0
Erratum0
The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients0
A Response and Discussion with Respect to Gulcelik’s Study in Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment0
Expert Discussion: Ductal Carcinoma in situ0
Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy0
PharmaNews0
PharmaNews0
Nipple-Sparing Mastectomy and Breast Reconstruction: Does Incision Matter?0
Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis0
Kombinationstherapie bei HER2+ mBC0
Prediction of Cardiac Toxicity by Measurement of Coronary Artery Calcium Scoring Method Using Chest Computed Tomography in Early Breast Cancer Patients Treated with Trastuzumab0
Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis0
Palbociclib: Neue 5-Jahres-OS-Daten aus RCT bei HR+/HER2– aBC0
Vitamin D and Breast Cancer Risk: Evaluating the Association and Effective Risk Reduction0
Expert Discussion: Predictive Markers0
PharmaNews0
Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report0
Front & Back Matter0
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation0
First-in-Class-Therapie mit Sacituzumab Govitecan0
ADC-basierte Therapie und Radiatio0
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer0
Sacituzumab govitecan: Trop-2 als Target0
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?0
PharmaNews0
Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?0
Expert Discussion: Immunotherapy in Breast Cancer – Ready for Prime Time?0
Front & Back Matter0
Front & Back Matter0
Front & Back Matter0
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative R0
Breast Reconstruction: Necessity for Further Standardization of the Current Surgical Techniques Attempting to Facilitate Scientific Evaluation and Select Tailored Individualized Procedures Optimizing 0
Junge Patientinnen mit frühem HER2-positivem Brustkrebs0
Effects and Risks of Hormonal Therapy before and after BC Therapy0
Front & Back Matter0
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti0
Sacituzumab Govitecan – hoch effektiv0
PharmaNews0
Front & Back Matter0
PharmaNews0
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2− Breast Cancer Patients0
Mammakarzinom: Phesgo im häuslichen Umfeld0
Expert Discussion: ASCO 20210
Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition0
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer0
Society Bulletins0
Acknowledgement to Reviewers0
PharmaNews0
PharmaNews0
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer0
Breast-Conserving Surgery with Immediate Partial Breast Reconstruction by Using Pedicled Thoracodorsal Artery Perforator Flap: A 7-Year Follow-Up of 50 Women0
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital0
Front & Back Matter0
Contents Vol. 18, 20230
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)0
Acupuncture for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer: An Umbrella Review0
Front & Back Matter0
Acknowledgement to Reviewers0
Expert Discussion: SABCS 20210
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study0
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”0
Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience0
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?0
Acknowledgement to Reviewers0
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts0
Clinical Outcomes in Breast Cancer Patients with HER2-Positive, Node-Negative Tumors (≤3 cm)0
Front & Back Matter0
Front & Back Matter0
Front & Back Matter0
Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care0
PharmaNews0
Erratum0
PharmaNews0
PharmaNews0
Insights from ASCO 20230
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries0
Is Reduction Mammoplasty Cost-Effective? A Cost-Utility Analysis of Surgical Treatment for Macromastia in Germany0
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 20180
Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers0
Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer0
PharmaNews0
Expert Discussion: HER2-Positive Breast Cancer0
Contents Vol. 17, 20220
Erratum0
PharmaNews0
A Rare Case of Breast Malignancy in an Adolescent Woman: Lessons Learned from Diagnosis and Management0
PharmaNews0
PharmaNews0
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20240
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer0
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience0
Front & Back Matter0
Interview ABC7: Bridging the Gap0
PharmaNews0
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts0
Front & Back Matter0
PharmaNews0
Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia0
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati0
PharmaNews0
Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature0
News from the San Antonio Breast Cancer Symposium 20220
Budget Impact of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany0
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants0
Management von Antikörper-Wirkstoff-Konjugaten bei mBC0
Front & Back Matter0
Front & Back Matter0
Front & Back Matter0
PharmaNews0
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation0
Concerning de Oliveira-Junior et al. “Oncoplastic Surgery in Breast-Conserving Treatment: Patient Profile and Impact on Quality of Life.” Breast Care. 2021;16(3):243–2530
Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy0
Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer0
0.06616997718811